CPI-818
Relapsed/Refractory Peripheral T-cell Lymphoma
Phase 3Active (FDA cleared)
Key Facts
Indication
Relapsed/Refractory Peripheral T-cell Lymphoma
Phase
Phase 3
Status
Active (FDA cleared)
Company
About Angel Pharmaceuticals
A Chinese biotech developing first-in-class and best-in-class oncology/autoimmune drugs through global partnerships and internal R&D.
View full company profile